353 related articles for article (PubMed ID: 16183515)
21. Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients.
Einsele H; Loeffler J
Clin Microbiol Infect; 2008 May; 14 Suppl 4():37-45. PubMed ID: 18430128
[TBL] [Abstract][Full Text] [Related]
22. [Sero-diagnosis for pulmonary aspergillosis--its utility in early diagnosis].
Niki Y
Rinsho Byori; 1996 Jun; 44(6):518-23. PubMed ID: 8752728
[TBL] [Abstract][Full Text] [Related]
23. [Usefulness of galactomannan detection in the diagnosis and follow-up of hematological patients with invasive aspergillosis].
Moragues MD; Amutio E; García-Ruiz JC; Pontón J
Rev Iberoam Micol; 2003 Sep; 20(3):103-10. PubMed ID: 15456366
[TBL] [Abstract][Full Text] [Related]
24. [Laboratory diagnosis of invasive aspergillosis].
del Palacio A; Cuétara MS; Pontón J
Rev Iberoam Micol; 2003 Sep; 20(3):90-8. PubMed ID: 15456364
[TBL] [Abstract][Full Text] [Related]
25. [Value of Aspergillus galactomannan antigen detection in the diagnosis and follow-up of invasive aspergillosis in hematological patients].
Jarque I; Andreu R; Salavert M; Gómez D; Pemán J; Gobernado M; Sanz MA
Rev Iberoam Micol; 2003 Sep; 20(3):116-8. PubMed ID: 15456368
[TBL] [Abstract][Full Text] [Related]
26. Utility of Aspergillus antigen detection in specimens other than serum specimens.
Klont RR; Mennink-Kersten MA; Verweij PE
Clin Infect Dis; 2004 Nov; 39(10):1467-74. PubMed ID: 15546083
[TBL] [Abstract][Full Text] [Related]
27. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of DNA, (1-3)-beta-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus.
Ahmad S; Khan ZU; Theyyathel AM
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):165-71. PubMed ID: 17574786
[TBL] [Abstract][Full Text] [Related]
29. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
[TBL] [Abstract][Full Text] [Related]
30. Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies.
Hoenigl M; Salzer HJ; Raggam RB; Valentin T; Rohn A; Woelfler A; Seeber K; Linkesch W; Krause R
Med Mycol; 2012 Apr; 50(3):266-9. PubMed ID: 21905944
[TBL] [Abstract][Full Text] [Related]
31. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies.
Rogers TR; Morton CO; Springer J; Conneally E; Heinz W; Kenny C; Frost S; Einsele H; Loeffler J
Br J Haematol; 2013 May; 161(4):517-24. PubMed ID: 23614624
[TBL] [Abstract][Full Text] [Related]
32. Trends in invasive fungal infections, with emphasis on invasive aspergillosis.
Erjavec Z; Kluin-Nelemans H; Verweij PE
Clin Microbiol Infect; 2009 Jul; 15(7):625-33. PubMed ID: 19673973
[TBL] [Abstract][Full Text] [Related]
33. Serial Aspergillus antigen monitoring in pediatric bone marrow transplant patients.
Baker C
J Pediatr Oncol Nurs; 2006; 23(6):300-4. PubMed ID: 17035619
[TBL] [Abstract][Full Text] [Related]
34. Design issues in studies evaluating diagnostic tests for aspergillosis.
Marr KA; Leisenring W
Clin Infect Dis; 2005 Sep; 41 Suppl 6():S381-6. PubMed ID: 16108003
[TBL] [Abstract][Full Text] [Related]
35. Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders.
Maertens J; Theunissen K; Lodewyck T; Lagrou K; Van Eldere J
Mycoses; 2007; 50 Suppl 1():2-17. PubMed ID: 17394605
[TBL] [Abstract][Full Text] [Related]
36. The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.
Ambasta A; Carson J; Church DL
Med Mycol; 2015 Aug; 53(6):531-57. PubMed ID: 26026174
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of invasive aspergillosis: recent developments and ongoing challenges.
Arvanitis M; Mylonakis E
Eur J Clin Invest; 2015 Jun; 45(6):646-52. PubMed ID: 25851301
[TBL] [Abstract][Full Text] [Related]
38. Clinical utility and development of biomarkers in invasive aspergillosis.
Patterson TF
Trans Am Clin Climatol Assoc; 2011; 122():174-83. PubMed ID: 21686223
[TBL] [Abstract][Full Text] [Related]
39. Critical assessment of issues in the diagnosis of invasive aspergillosis.
Klont RR; Meis JF; Verweij PE
Clin Microbiol Infect; 2001; 7 Suppl 2():32-7. PubMed ID: 11525216
[TBL] [Abstract][Full Text] [Related]
40. Assessment of Platelia Aspergillus enzyme immunoassay for the diagnosis of invasive aspergillosis.
Lai CC; Hsu HL; Lee LN; Hsueh PR
J Microbiol Immunol Infect; 2007 Apr; 40(2):148-53. PubMed ID: 17446963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
